Loading...

Home
ETF
VTGN

VTGN

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

VTGN News

Class Action Filed Against Vistagen Therapeutics for Securities Violations

5h agoGlobenewswire

Vistagen Therapeutics Faces Class Action Lawsuit for Securities Violations

7h agoGlobenewswire

Vistagen Investors Warned of Class Action Lawsuit

8h agoGlobenewswire

Vistagen Class Action Notice for Investors

1d agoGlobenewswire

Vistagen Faces Securities Litigation Investigation

2d agoGlobenewswire

Vistagen Therapeutics Accused of Misleading Investors

3d agoGlobenewswire

Vistagen Faces Class Action Lawsuit Reminder

3d agoGlobenewswire

Applied Materials Reports Strong Q1 Results, Shares Surge

Vistagen Therapeutics Class Action Notice Issued

3d agoPRnewswire

Vistagen Therapeutics Q3 2026 Earnings Call Highlights

3d agoseekingalpha

VistaGen Therapeutics Q3 Earnings Beat Expectations

4d agoseekingalpha

Vistagen Faces Securities Fraud Class Action Lawsuit

4d agoGlobenewswire

VistaGen Therapeutics Q3 Earnings Announcement Scheduled

5d agoseekingalpha

Vistagen Lawsuit Reminder for Investors

5d agoGlobenewswire

Vistagen Lawsuit Reminder for Investors

5d agoGlobenewswire

Faruqi & Faruqi Encourages Vistagen Investors to Reach Out

5d agoPRnewswire